222 related articles for article (PubMed ID: 24735610)
1. The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
Orqueda AJ; Dansey MV; Español A; Veleiro AS; Bal de Kier Joffé E; Sales ME; Burton G; Pecci A
Biochem Pharmacol; 2014 Jun; 89(4):526-35. PubMed ID: 24735610
[TBL] [Abstract][Full Text] [Related]
2. Exploring the molecular basis of action of the passive antiglucocorticoid 21-hydroxy-6,19-epoxyprogesterone.
Alvarez LD; Martí MA; Veleiro AS; Presman DM; Estrin DA; Pecci A; Burton G
J Med Chem; 2008 Mar; 51(5):1352-60. PubMed ID: 18284186
[TBL] [Abstract][Full Text] [Related]
3. Hemisuccinate of 21-hydroxy-6,19-epoxyprogesterone: a tissue-specific modulator of the glucocorticoid receptor.
Alvarez LD; Martí MA; Veleiro AS; Misico RI; Estrin DA; Pecci A; Burton G
ChemMedChem; 2008 Dec; 3(12):1869-77. PubMed ID: 18985652
[TBL] [Abstract][Full Text] [Related]
4. 21-Hydroxy-6,19-epoxyprogesterone: A Promising Therapeutic Agent and a Molecular Tool for Deciphering Glucocorticoid Action.
Pecci A; Alvarez LD; Presman DM; Burton G
Mini Rev Med Chem; 2018 Feb; 18(5):428-438. PubMed ID: 26776223
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
6. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
Runnebaum IB; Brüning A
Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
[TBL] [Abstract][Full Text] [Related]
9. The aerial part of Taraxacum coreanum extract has an anti-inflammatory effect on peritoneal macrophages in vitro and increases survival in a mouse model of septic shock.
Lee MH; Kang H; Lee K; Yang G; Ham I; Bu Y; Kim H; Choi HY
J Ethnopharmacol; 2013 Mar; 146(1):1-8. PubMed ID: 23261487
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
Skor MN; Wonder EL; Kocherginsky M; Goyal A; Hall BA; Cai Y; Conzen SD
Clin Cancer Res; 2013 Nov; 19(22):6163-72. PubMed ID: 24016618
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts.
Drebert Z; Bracke M; Beck IM
J Steroid Biochem Mol Biol; 2015 May; 149():92-105. PubMed ID: 25666906
[TBL] [Abstract][Full Text] [Related]
12. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
Chen Z; Lan X; Wu D; Sunkel B; Ye Z; Huang J; Liu Z; Clinton SK; Jin VX; Wang Q
Nat Commun; 2015 Sep; 6():8323. PubMed ID: 26374485
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids.
Chivers JE; Gong W; King EM; Seybold J; Mak JC; Donnelly LE; Holden NS; Newton R
Mol Pharmacol; 2006 Dec; 70(6):2084-95. PubMed ID: 16988013
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor and breast cancer.
Vilasco M; Communal L; Mourra N; Courtin A; Forgez P; Gompel A
Breast Cancer Res Treat; 2011 Nov; 130(1):1-10. PubMed ID: 21818591
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis.
Pang D; Kocherginsky M; Krausz T; Kim SY; Conzen SD
Cancer Biol Ther; 2006 Aug; 5(8):933-40. PubMed ID: 16775428
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term.
Patel FA; Funder JW; Challis JR
J Clin Endocrinol Metab; 2003 Jun; 88(6):2922-33. PubMed ID: 12788907
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
Lesovaya EA; Yemelyanov AY; Kirsanov KI; Yakubovskaya MG; Budunova IV
Biochemistry (Mosc); 2011 Nov; 76(11):1242-52. PubMed ID: 22117551
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid receptors take part in the apoptotic process of human lens epithelial cells, but the glucocorticoid receptor antagonist RU486 does not rescue the cells fully.
Wang L; Zhao W; Leng F; Ge J; Bu Z; Zhang Y; Liu P
Mol Biosyst; 2011 Jun; 7(6):1926-37. PubMed ID: 21451860
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
